Prognostic Value of Negative Lymph Nodes Count in Solid Tumors
10.3971/j.issn.1000-8578.2022.21.1523
- VernacularTitle:阴性淋巴结数目在实体肿瘤预后中的价值
- Author:
Jinzhou LI
1
;
Zeping HUANG
;
Yanxi MU
;
Yalong YAO
;
Wenjie WANG
;
Haipeng LIU
;
Jie LIU
;
Zhou WANG
;
Xiao CHEN
Author Information
1. The Second Clinical Medical College of Lanzhou University, Lanzhou 730000, China
- Publication Type:Research Article
- Keywords:
Solid tumors;
Negative lymph nodes count;
Prognosis;
Pathological staging system
- From:
Cancer Research on Prevention and Treatment
2022;49(8):843-849
- CountryChina
- Language:Chinese
-
Abstract:
The postoperative pathological staging system (pTNM) has become an important reference for the selection of various tumor treatment strategies and prognosis evaluation at a global scale, and is a powerful predictor of the prognosis of a variety of solid tumors, but the prognosis is still different in patients with the same pTNM staging. In recent years, studies have confirmed that the negative lymph nodes count (NLNC) is related to the prognosis of a variety of solid tumors. Higher NLNC can improve the prognosis of cancer patients, and NLNC can reduce staging migration, which is expected to be a supplement to the pTNM staging system. This article reviews the value of NLNC in the prognosis of solid tumors.
